Galderma brings together more than 650 healthcare professionals from across Asia Pacific to advance knowledge of future aesthetic trends

Galderma (SWX:GALD), a leader in pure dermatology, today announced a new edition of the Galderma Aesthetic Injector Network (GAIN) event in the Asia Pacific region, home to some of the company’s fastest growing markets . This is the largest regional event to date and will provide a premium and engaging experience for more than 650 participants. The comprehensive, two-day agenda, taking place from October 26 to 27 in Incheon, South Korea, will delve deep into the six trends identified in the ‘NEXT by Galderma’ report and explore how they shape the future of aesthetics will shape.¹

Aesthetics are increasingly becoming part of beauty and wellness routines worldwide, which in turn are driving much of the growth in this category. By 2028, the aesthetic products market is expected to nearly double in value to $25.9 billion.⁴ GAIN is Galderma’s long-standing training platform, designed to educate, inspire and empower by creating a unique community of highly trained, clinically skilled aesthetic practitioners. Created by aesthetic practitioners for aesthetic practitioners, GAIN’s primary purpose is to encourage and facilitate knowledge sharing and improve the treatment experience for both patients and aesthetic practitioners themselves.

“We are excited to bring together GAIN’s aesthetic community in the Asia Pacific region, which hosts some of our fastest growing markets and is a key driver of the continued strong commercial performance of our broad and unique portfolio. Built around the six key trends from our groundbreaking ‘NEXT by Galderma’ report, which are expected to drive demand and shape the future, this event is designed to bring the latest in medical aesthetics science and skills and to help the entire segment move forward.”

HON KEONG CHOO

HEAD OF JPAC

GALDERMA

With one of the highest demands on aesthetics,^2.3 Asia Pacific is home to some of Galderma’s fastest growing markets, where sales have fueled the company’s strong performance across all product categories. There have already been several successes in the region this year, with the launches of many key aesthetic products, including Restylane® VOLYME in China,⁵ Restylane® EYELIGHT in Korea⁶ and Alastin Skincare® in Australia.⁷ More recently, Relfydess^T.M (RelabotulinumtoxinA) was approved in Australia⁸ and Sculptra® – which is celebrating its 25th anniversary^e launch anniversary this year – was approved in China.⁹ With its premiumization strategy and broad channel exposure, Galderma is well positioned to capitalize on growing consumer demand in the Asia Pacific, where the attractive dermatology market has remained on a consistent growth trajectory, with robust demand for high-quality, science-based products.

“The field of aesthetics is evolving rapidly, and this is having a real impact on our practice in the Asia Pacific region. Events such as GAIN JPAC, where practicing physicians have the opportunity to dive deep into future trends, techniques and products in the fields of aesthetics are invaluable in helping us tailor our approach to each skin story, stay abreast of the ever-changing demands we face, and ultimately continue to deliver the excellence our patients expect.”

VAN PARK, BSC(MED), MBBS

COSMETIC PHYSICIAN AND FOUNDER, DVP, SYDNEY

The event program is built around the six global aesthetic trends identified by ‘NEXT by Galderma’, a groundbreaking report based on a year of extensive trend forecasting research conducted in collaboration with a network of renowned experts:¹

Proactive beauty: an increased shift toward early intervention in aging.

Mindful Aesthetics: The prioritization of products with minimal environmental impact that align with patients’ ethical values and deliver natural-looking results.

Fast Aesthetics: More and more people now want to use aesthetics to emulate the latest, fast-changing trends.

Beauty Fandom: A reflection of patients’ fascination with niche glorification – from cultural icons to digital filters, anime and more – leading to a desire for metamorphosis.

Expressionality: A celebration of the empowerment that comes from creating and strengthening one’s identity through aesthetics.

Cancel age: We’re canceling expectations of what certain ages “should look like” as consumers use aesthetics to express their ageless attitude.

In addition, research will explore the potential of aesthetics to help the increasing number of patients experiencing rapid weight loss, and how this could impact the aesthetic landscape in this region in the future.

The event’s agenda features a faculty of 10 renowned global and Asia-Pacific experts. Expert presentations, live demonstrations, case sharing and panel discussions will bring Galderma’s integrated dermatology strategy to life with sessions aimed at advancing skin science, skin education and skin innovation, while further strengthening the GAIN community. Additional ‘GAIN Talks’ on topics such as reverse aging and ethics in aesthetics, as well as several Meet The Expert sessions throughout the two-day event will further strengthen Galderma’s leadership in dermatology and the cumulative knowledge of the GAIN community, helping the company stand out as a true leader and partner of choice in the sector.

About Galderma

Galderma (SIX: GALD) is the market leader in pure dermatology and is present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services covering the full spectrum of the fast-growing dermatology market through injectable aesthetics, dermatological skin care and therapeutic dermatology. Since our founding in 1981, we have dedicated our focus and passion to the largest organ of the human body – the skin – to meet the individual needs of consumers and patients with superior results in collaboration with healthcare professionals. Because we understand that the skin we are in determines our lives, we promote dermatology for every skin story. For more information: www.galderma.com.

References:

NEXT by Galderma. Emerging aesthetic trend report. 2023. Available online. Last accessed October 2024

Kwon SH, et al. Experiences and attitudes toward aesthetic procedures in East Asia: a cross-sectional study of five geographic regions. Archplast Surg. 2021 Nov;48(6):660-669. doi: 10.5999/aps.2020.02565. Epub Nov 15 2021. PMID: 34818714; PMCID: PMC8627936.

Asia Pacific Medical Aesthetics Market Size, Share and Industry Trends Analysis Report by End User (Clinics, Hospitals & Medical Spas, Beauty Centers and Home Healthcare Facilities), by Procedure, by Product, by Country and Growth Forecast, 2023 – 2030. Available online. Last accessed October 2024

Markets and Markets (2023) Medical Aesthetics Market by product (botox, filler, peeling, implant, liposuction, microneedling, hair removal, laser resurfacing, RF, phototherapy), procedure (surgical, non-surgical), end user (hospital, beauty clinic, spa), region – global forecast to 2028. Available online. Last accessed October 2024

Galderma. Galderma launches Restylane® Volyme™ in China – one of the fastest growing aesthetic markets in the world. Available online. Last accessed October 2024

Korea BioMed. Galderma Korea launches ‘Restylane Eyelight’ in June. Available online. Last accessed October 2024

Galderma. Alastin.com.au. Alastin Skincare now available in Australia. Available online. Last accessed October 2024

Galderma. Galderma’s Relfydess™ (RelabotulinumtoxinA) receives positive decision for use in Europe. Available online. Last accessed October 2024

Galderma. Galderma achieves record net sales of USD 3.259 billion in the first nine months of 2024, demonstrating significant progress in innovation, confirming and strengthening full-year net sales expectations. Available online. Last accessed October 2024

View the source version on businesswire.com: https://www.businesswire.com/news/home/20241024310758/en/